Screener
Myriad Genetics MYGN Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Myriad Genetics in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Myriad Genetics’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 6:05 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000899923-26-000038
| Line item | Three months ended March 31, 2026 | 2025 |
|---|---|---|
| General and administrative expense | 62.2 | 66.5 |
| Goodwill and long-lived asset impairment charges | 5.4 | — |
| Total operating expenses | 168.3 | 163.2 |
| Operating loss | (30.7) | (29.0) |
| Other income (expense): | ||
| Interest income | 0.7 | 0.3 |
| Interest expense | (4.1) | (0.8) |
| Other | — | 0.1 |
Item 1. Financial Statements.
FAQ
- What is Myriad Genetics's operating income?
- Myriad Genetics (MYGN) reported operating income of -$30.7M in Q1 2026.
- How has Myriad Genetics's operating income changed year-over-year?
- Myriad Genetics's operating income decreased by 5.9% year-over-year, from -$29M to -$30.7M.
- What is the long-term trend for Myriad Genetics's operating income?
- Over 4 years (2021 to 2025), Myriad Genetics's operating income has grown at a 19.4% compound annual growth rate (CAGR), from -$190.5M to -$387.2M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about Myriad Genetics's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude